
Overview
Background
Kwun is a Thoracic and Sleep Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre (UQTRC). His research interests are focussed on making and translating research discoveries to improving outcomes and the health of people who are affected by lung disease particularly lung cancer screening/early detection and biomarkers. The UQTRC is also passionate at enabling productive collaborations to maximise research impact and scale with contributions to The Cancer Genome Atlas Project, Pan-Cancer Analysis of Whole Genomes (PCAWG), IASLC Lung Cancer Staging Project and others.
Availability
- Professor Kwun Fong is:
- Available for supervision
Fields of research
Research impacts
Lung cancer is the leading cause of cancer mortality in Australia and globally. The prevention, early detection/screening and optimal management of lung cancer will help address the huge burden from lung cancer, enabled by high impact research and addressing stigma and nihilism and the health disparities that exist.
The team at The Prince Charles Hospital and University of Queensland Thoracic Research Centre are passionate, focussed and internationally recognised, leading clinical research in lung cancer in Australia. They are very pleased and privileged to work with patients, families / carers and consumers to make a difference in this awful disease.
Works
Search Professor Kwun Fong’s works on UQ eSpace
2006
Other Outputs
Tumors, Malignant: Bronchogenic Carcinoma
Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Bronchogenic Carcinoma.
2006
Book Chapter
TUMORS, MALIGNANT | Metastases from Lung Cancer
Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). TUMORS, MALIGNANT | Metastases from Lung Cancer. Encyclopedia of Respiratory Medicine: Volume 1-4. (pp. V4-350-V4-356) Elsevier. doi: 10.1016/B0-12-370879-6/00412-9
2006
Other Outputs
Tumors, Malignant: Overview
Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Overview.
2006
Book Chapter
Tumors, malignant: bronchogenic carcinoma
Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, malignant: bronchogenic carcinoma. Encyclopedia of respiratory medicine. (pp. 325-332) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00408-7
2006
Conference Publication
Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors
Molenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC.
2006
Journal Article
CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung
Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2006). CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27 (3), 525-532. doi: 10.1093/carcin/bgi227
2006
Journal Article
Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland
Coory, M., Fong, K., Bowman, R. and Hall, L. (2006). Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland. Internal Medicine Journal, 36 (6), 389-392. doi: 10.1111/j.1445-5994.2006.01074.x
2005
Journal Article
Cochrane systematic reviews of treatments for lung cancer
Fong, K. M., Yang, I .A., Zimmerman, P. V. and Bowman, R. V. (2005). Cochrane systematic reviews of treatments for lung cancer. Respiratory Medicine, 99 (9), 1071-1078. doi: 10.1016/j.rmed.2005.05.002
2005
Journal Article
Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation
Zochbauer-Muller, Sabine, Fong, Kwun M., Geradts, Joseph, Xu, Xie, Seidl, Sonja, End-Pfützenreuter, Adelheid, Lang, György, Heller, Gerwin, Zielinski, Christoph C., Gazdar, Adi F. and Minna, John D. (2005). Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene, 24 (41), 6249-6255. doi: 10.1038/sj.onc.1208775
2005
Journal Article
Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism
Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2005). Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes and Control, 16 (5), 579-585. doi: 10.1007/s10552-004-7842-3
2005
Journal Article
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin
Tothill, R.W., Kowalczyk, A., Rischin, D., Bousioutas, A., Haviv, I., van Laar, R.K., Waring, P.M., Zalcberg, J., Ward, R., Biankin, A.V., Sutherland, R.L., Henshall, S.M., Fong, K., Pollack, J.R., Bowtell, D.D.L. and Holloway, A.J. (2005). An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Research, 65 (10), 4031-4040. doi: 10.1158/0008-5472.CAN-04-3617
2005
Journal Article
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
Shigematsu, Hisayuki, Lin, Li, Takahashi, Takao, Nomura, Masaharu, Suzuki, Makoto, Wistuba, Ignacio I., Fong, Kwun M., Lee, Huei, Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Feng, Ziding, Roth, Jack A., Herz, Joachim, Minna, John, D. and Gazdar, Adi, F. (2005). Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. Journal of the National Cancer Institute, 97 (5), 339-346. doi: 10.1093/jnci/dji055
2005
Journal Article
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas
Shigematsu, Hisayuki, Takahashi, Takao, Nomura, Masaharu, Majmudar,Kuntal, Suzuki, Makoto, Lee, Huei, Wistuba, Ignacio I., Fong, Kwun M., Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Minna, John D. and Gazdar, Adi F. (2005). Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Research, 65 (5), 1642-1646. doi: 10.1158/0008-5472.CAN-04-4235
2005
Other Outputs
Molecular Biology of Lung Cancer
Sekido, Y., Fong, K M. and Minna, J. D. (2005). Molecular Biology of Lung Cancer.
2005
Conference Publication
Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003
Fong, K., Bowman, R., Abraham, R., Windsor, M., Pratt, G., Fielding, D., Armstrong, J. and Zimmerman, P. (2005). Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003. 11th World Conference on Lung Cancer, Barcelona, Spain, 3–6 July, 2005. Shannon, Co. Clare, Ireland: Elsevier Science. doi: 10.1016/S0169-5002(05)80820-7
2005
Conference Publication
Key molecular markers of proliferation, cell cycling and survival map topographically to areas of abnormal morphology, but do not predict occurrence of bronchial preneoplasia in smokers
Bowman, R., Maclachlan, R., Clarke, B., Duhig, E. and Fong, K. (2005). Key molecular markers of proliferation, cell cycling and survival map topographically to areas of abnormal morphology, but do not predict occurrence of bronchial preneoplasia in smokers. 11th World Conference on Lung Cancer, Barcelona, Spain, 3rd – 6 July, 2005. CLARE: ELSEVIER IRELAND LTD. doi: 10.1016/S0169-5002(05)80385-X
2005
Conference Publication
P-239 Phosphorylation status of the retinoblastoma protein inpreneoplastic bronchial epithelium
Bowman, R., MacLachlan, R., Clarke, B., Duhig, E., Davidson, M. and Fong, K. (2005). P-239 Phosphorylation status of the retinoblastoma protein inpreneoplastic bronchial epithelium. Abstract of the 11th World Conference on Lung Cancer, Barcelona, Spain, 3–6 July 2005. Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80733-0
2005
Conference Publication
Expression profiling of metastatic recurrence in primary bronchogenic squamous cell carcinomas
Larsen, J., Pavey, S., Passmore, L., Bowman, R., Hayward, N., Zimmerman, P. and Fong, K. (2005). Expression profiling of metastatic recurrence in primary bronchogenic squamous cell carcinomas. 11th World Conference on Lung Cancer, Barcelona, Spain, 03-06 July 2005. Shannon, Co. Clare, Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80568-9
2005
Journal Article
Effectiveness of hospital-based smoking cessation
Fung, Pamela R., Snape-Jenkinson, Stella L., Godfrey, Maureen T., Love, Keith W., Zimmerman, Paul V., Yang, Ian A. and Fong, Kwun M. (2005). Effectiveness of hospital-based smoking cessation. Chest, 128 (1), 216-223. doi: 10.1378/chest.128.1.216
2005
Conference Publication
Expression profiling of metastatic recurrence in primary bronchogenic squamous cell
Larsen, J., Pavey, S., Passmore, L., Bowman, R., Hayward, N., Zimmerman, P. and Fong, K. (2005). Expression profiling of metastatic recurrence in primary bronchogenic squamous cell. 11th World Conference on Lung Cancer 2005, Barcelona, Spain, 3-6 July 2005. Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80568-9
Funding
Current funding
Supervision
Availability
- Professor Kwun Fong is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.
Principal Advisor
Other advisors: Professor Ian Yang
-
Doctor Philosophy
Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer
Principal Advisor
Other advisors: Professor Ian Yang
-
Doctor Philosophy
Combined Compressed sensing and machine learning/deep learning methods for rapid MRI
Associate Advisor
Other advisors: Associate Professor Henry Marshall, Dr Hongfu Sun, Professor Feng Liu
-
Doctor Philosophy
Blood biomarkers for lung cancer screening
Associate Advisor
Other advisors: Professor Ian Yang, Associate Professor Henry Marshall
-
Master Philosophy
Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)
Associate Advisor
Other advisors: Professor Ian Yang
-
Doctor Philosophy
Effectiveness of Non-invasive Ventilation for the treatment of nocturnal hypoventilation in Myotonic Dystrophy
Associate Advisor
Other advisors: Professor Elizabeth Coulson
-
Master Philosophy
A multivariable prediction model for osteoporotic fracture and low bone density in a lung cancer screening cohort
Associate Advisor
Other advisors: Professor Ian Yang, Associate Professor Henry Marshall
-
Completed supervision
-
2024
Doctor Philosophy
Screening For Biomarkers in Non-Small Cell Lung Cancer
Principal Advisor
Other advisors: Professor Ian Yang
-
2021
Doctor Philosophy
Evaluating NanoString Technology to Enhance the Molecular Characterisation of Lung Cancer
Principal Advisor
Other advisors: Professor Ian Yang
-
2021
Doctor Philosophy
Retrospective cohort studies on the lung cancer secondary care diagnostic pathway: Factors that influence waiting time intervals and patient experience
Principal Advisor
Other advisors: Professor Ian Yang
-
2015
Master Philosophy
Lung cancer in rural and remote Aboriginal and Torres Strait Islander communities in Queensland: Awareness and identifying health needs in a cultural context.
Principal Advisor
Other advisors: Professor Ian Yang
-
2015
Doctor Philosophy
The Queensland Lung Cancer Screening Study
Principal Advisor
Other advisors: Professor Ian Yang, Associate Professor Paul Zimmerman
-
2014
Doctor Philosophy
MOLECULAR MECHANISMS UNDERLYING PROGRESSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Principal Advisor
Other advisors: Professor Ian Yang
-
2014
Doctor Philosophy
Genomic characterisation of asbestos-related lung cancer
Principal Advisor
Other advisors: Professor Ian Yang
-
2013
Doctor Philosophy
MOLECULAR BIOMARKERS IN THORACIC ONCOLOGY
Principal Advisor
Other advisors: Professor Ian Yang
-
2013
Doctor Philosophy
Aberrant microRNA Expression in Lung Cancer
Principal Advisor
Other advisors: Professor Ian Yang
-
Doctor Philosophy
GENOMIC PROFILING OF TUMOR RECURRENCE IN NON-SMALL-CELL LUNG CARCINOMA
Principal Advisor
-
2022
Doctor Philosophy
Evaluation of Pleural Fluid Extracellular Vesicles for Diagnostic Utility in Malignant Pleural Mesothelioma
Associate Advisor
Other advisors: Professor Ian Yang
-
2021
Master Philosophy
The Clinical Journey of Patients with a Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD): from the Ambulance to the Emergency Department to the Hospital Ward
Associate Advisor
Other advisors: Professor Ian Yang
-
2021
Doctor Philosophy
Diagnostic, prognostic and therapeutic applications of extracellular vesicles in chronic obstructive pulmonary disease and lung cancer
Associate Advisor
Other advisors: Professor Ian Yang
-
2019
Master Philosophy
Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation
Associate Advisor
Other advisors: Professor Ian Yang
-
2018
Doctor Philosophy
The response of human bronchial epithelial cells to outdoor air pollution: Interventions to protect the diseased lung against diesel emission exposure
Associate Advisor
Other advisors: Professor Ian Yang
-
2017
Doctor Philosophy
The Role of Exhaled Breath Analysis in the Diagnosis and Monitoring of Lung Diseases
Associate Advisor
Other advisors: Associate Professor David Fielding, Professor Ian Yang, Associate Professor Paul Zimmerman
-
2012
Master Philosophy
Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD)
Associate Advisor
Other advisors: Professor Ian Yang, Associate Professor Paul Zimmerman
-
2002
Doctor Philosophy
MOLECULAR INFLUENCES ON AIRWAYS DISEASE PATHOGENESIS, SUSCEPTIBILITY AND TREATMENT.
Associate Advisor
Other advisors: Associate Professor Paul Zimmerman
Media
Enquiries
For media enquiries about Professor Kwun Fong's areas of expertise, story ideas and help finding experts, contact our Media team: